Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aparna Balachandran

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Abdominal Imaging|June 19, 2012
Pancreatic neuroendocrine neoplasms: diagnosis and managementAparna Balachandran, Eric P Tamm, Priya R Bhosale, et al.
Radiologic Clinics of North America|May 8, 2012
Imaging of pancreatic adenocarcinoma: update on staging/resectabilityEric P Tamm, Aparna Balachandran, Priya R Bhosale, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 19, 2015
Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine TumorsLaura Prakash, Jeffrey E Lee, James Yao, et al.
Journal of Computer Assisted Tomography|January 31, 2015
CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRI at 1.5 T: a comparative in vivo patient studyAjaykumar C Morani, Rafael A Vicens, Wei Wei, et al.
Journal of the American College of Surgeons|July 31, 2010
Multidisciplinary management strategy for incidental cystic lesions of the pancreasDebashish Bose, Eric Tamm, Jun Liu, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 27, 2017
BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and ManagementMichelle V Lee, Venkata S Katabathina, Michyla L Bowerson, et al.
Annals of Diagnostic Pathology|November 5, 2011
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosisQing Zhao, Asif Rashid, Yun Gong, et al.
Cancer|May 19, 2012
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicatorsMatthew H G Katz, Jason B Fleming, Priya Bhosale, et al.
Annals of Surgical Oncology|January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Abdominal Imaging|June 19, 2012
Pancreatic neuroendocrine neoplasms: diagnosis and managementAparna Balachandran, Eric P Tamm, Priya R Bhosale, et al.
Radiologic Clinics of North America|May 8, 2012
Imaging of pancreatic adenocarcinoma: update on staging/resectabilityEric P Tamm, Aparna Balachandran, Priya R Bhosale, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 19, 2015
Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine TumorsLaura Prakash, Jeffrey E Lee, James Yao, et al.
Journal of Computer Assisted Tomography|January 31, 2015
CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRI at 1.5 T: a comparative in vivo patient studyAjaykumar C Morani, Rafael A Vicens, Wei Wei, et al.
Journal of the American College of Surgeons|July 31, 2010
Multidisciplinary management strategy for incidental cystic lesions of the pancreasDebashish Bose, Eric Tamm, Jun Liu, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 27, 2017
BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and ManagementMichelle V Lee, Venkata S Katabathina, Michyla L Bowerson, et al.
Annals of Diagnostic Pathology|November 5, 2011
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosisQing Zhao, Asif Rashid, Yun Gong, et al.
Cancer|May 19, 2012
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicatorsMatthew H G Katz, Jason B Fleming, Priya Bhosale, et al.
Annals of Surgical Oncology|January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Pageof 5